14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 121 days ( -139.60 % )
Last Price $16.70 0 %
High/ Low $16.70 - $16.70 0%
Chg 7 Days N/A $16.70 $16.70
Chg 30 Days N/A $16.70 $16.70
Chg 12 mos 258.37 % $4.66 $16.70
Trend - 3 mos 2.17 % Width: 1.23 %
Trend - 12 mos 322.32 % Width: 63.80 %
Pred. range - 3 mos $17.02 - $17.23 1.94 % - 3.19 %
Pred. range - 12 mos $57.06 - $93.47 241.68 % - 459.69 %
Short MA avg 3 mos Buy Jan 09, 2024 - 47 days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Sell Jan 10, 2024 - 46 days
Long MA avg 12 mos Buy Sep 14, 2023 - 127 days
Short/Long MA avg 12 mos Buy Sep 19, 2023 - 124 days
Pivot Short Sell Mar 14, 2024 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Orchard Therapeutics plc

Orchard Therapeutics plc Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's disease through a single administration. It provides Strimvelis, a gammaretroviral-based product for the... ORTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT